Proper assessment of medical values and innovativeness of IVDs

The medical value and innovativeness of IVDs have not been directly reflected to reimbursement point discussion, and the evaluation results of new and improved items at Chuikyo have not been published. It was agreed that ‘Challenge filing’ will be discussed for IVDs in the next round of reimbursement discussion.


  • Concrete discussion will be held for having ‘challenge filing’ for IVDs.
  • At the time of insurance coverage, the evaluation points for the medical values and innovativeness of the listed IVDs shall be specified and disclosed.